FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.360
+0.030 (2.26%)
Apr 2, 2026, 12:11 PM EDT - Market open
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $4.6 million as of April 2, 2026. Its market cap has decreased by -87.37% in one year.
Market Cap
4.60M
Enterprise Value
2.01M
1-Year Change
-87.37%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $4.60M, a decrease of -99.51%. That is a compound annual growth rate of -91.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 4.50M | -69.95% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Green Med Solution | 4.90M |
| KALA BIO | 4.89M |
| Dermata Therapeutics | 4.87M |
| Pulmatrix | 4.71M |
| Revelation Biosciences | 4.46M |
| Moolec Science | 4.30M |
| Can-Fite BioPharma | 4.27M |
| Silexion Therapeutics | 4.26M |